Home / norgestimate and ethinylestradiol / Canada
CA ATC G03AB09 · updated 2 Nov 2026
norgestimate and ethinylestradiol shortage in Canada
Is there a norgestimate and ethinylestradiol shortage in Canada?
Yes. As of 2 Nov 2026, 2 norgestimate and ethinylestradiol products are reported short in Canada, the first since 5 May 2026. No return date has been given. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TRI-CIRA 28 (28 BLS) | APOTEX INC | 5 May 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TRI-CIRA 21 (21 BLS) | APOTEX INC | 5 May 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.